Steven M. Weinman

FDA investigator

Appears on 3 documents from 2019 to 2020, mostly at sites in India. Most often cites control of microbiological contamination (21 CFR 211.113).

3
Documents on file
6.0
Observations per 483
2019
First seen
2020
Most recent

What they cite most

From 18 observations

Activity by year

2019: 1, 2020: 2

Where

India 2 · Japan 1

Is Steven M. Weinman coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 Mylan Laboratories LimitedFeb 28, 2020 · Bengaluru, India
483 Somerset Therapeutics Private LimitedFeb 19, 2020 · Bengaluru, India
483 Takeda Pharmaceutical Company LimitedNov 26, 2019 · Hikari, Japan

About this profile

What does Steven M. Weinman inspect?

Steven M. Weinman appears on 3 documents on file covering 3 sites, mostly in India.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.22 and 21 CFR 211.110.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Steven M. Weinman is dated Feb 28, 2020.